JamesGHowardMD
Ophthalmology • Murray, UTRetinal Disease, Ocular Oncology
Partner at Retina Associates of Utah
Dr. Howard is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5169 S Cottonwood St
Ste 630
Murray, UT 84107Phone+1 801-312-2020Fax+1 801-312-2022
Education & Training
University of Iowa Hospitals and ClinicsFellowship, Surgical Retina and Vitreous, 2005 - 2007- University of Iowa Hospitals and ClinicsResidency, Ophthalmology, 2002 - 2005
University of Utah HealthInternship, Internal Medicine, 2001 - 2002
University of Utah School of MedicineClass of 2001
Certifications & Licensure
UT State Medical License 2007 - 2026
IA State Medical License 2002 - 2009- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- Fellow (FAAO) American Academy of Ophthalmology
Clinical Trials
- Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema Start of enrollment: 2012 Aug 01
- Treatment for CI-DME in Eyes With Very Good VA Study Start of enrollment: 2013 Oct 01
- A Study Investigating the Efficacy and Safety of Lampalizumab Intravitreal Injections in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration Start of enrollment: 2014 Sep 18
- Join now to see all
Publications & Presentations
PubMed
- 316 citationsLifestyle Intervention for Pre-Diabetic NeuropathyA. Gordon Smith, James A. Russell, Eva L. Feldman, Jonathan Goldstein, Amanda Peltier
Diabetes Care. 2006-06-01 - 151 citationsThe Utah Early Neuropathy Scale: a sensitive clinical scale for early sensory predominant neuropathyJ. Robinson Singleton, Billie Bixby, James W. Russell, Eva L. Feldman, Amanda Peltier
Journal of the Peripheral Nervous System. 2008-09-01 - 58 citationsEnd-of-Study Results for the Ladder Phase 2 Trial of the Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration.Arshad M. Khanani, David Callanan, Richard Dreyer, Sanford Chen, James G. Howard
Ophthalmology. Retina. 2021-08-01
Professional Memberships
- Fellow
- Member
Other Languages
- Spanish
External Links
- Retina Associates of Utahhttp://www.retinautah.com
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
